Searched for
PHARMACEUTICAL MARKET IN UKRAINE
India, Russia prevented global economy from collapsing: IMEMO chiefRussia and India have forged a new global economic model, preventing global collapse and aiding the Global South with affordable resources....- ETMarkets Smart Talk | Defence and electrification are multi-year structural themes for India: Prateek AgrawalGeopolitical shifts and the drive for self-reliance are creating long-term investment opportunities in India's defence and electrification ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- Nifty at 25,900 by March 2027? Nomura cites key catalysts to watch out forIndian stocks have seen a sharp fall. Nomura predicts the Nifty will climb almost 11% to reach 25,900 by March 2027. This optimism stems fr...
- From axles to rare earth: India draws up list of 100 products it still can't make enough ofIndia is set to boost its manufacturing sector by identifying around 100 products for domestic production. This initiative aims to reduce r...
- Nifty to hit 42,000 by 2028? New paper that studied market cycles says it's possible if these factors alignA CNI InfoXchange study projects the Nifty could surpass 42,000 by 2028 if sustained foreign investor inflows return. The report highlights...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Why smallcap funds are still a buy: A long-term strategy from Aditya KhemaniSmallcap valuations seem high but underlying fundamentals have improved. Aditya Khemani of Invesco Mutual Fund sees this as a structural sh...
- Venus Remedies gets Ukrainian GMP renewal certificationVenus Remedies has received renewed GMP certification from Ukraine. This certification applies to its Baddi facility. It covers cephalospor...
- PM Modi, Ukraine's President Zelenskyy advocate for lasting peace through dialoguePrime Minister Narendra Modi visited Ukraine at the invitation of President Volodymyr Zelenskyy, marking the first visit by an Indian PM si...
- India, Ukraine ink four pacts; resolved to expand defence, trade tiesIndia and Ukraine signed four agreements on Friday, resolving to bolster their cooperation in areas such as defence, trade, pharmaceuticals...
- Venus Remedies gets marketing authorisations for three cancer drugs from UkraineSaransh Chaudhary, President, Global Critical Care, Venus Remedies, said, "These marketing approvals mark a significant milestone in our gl...
- Moscow says India may replace West in Russian pharmaceuticals market"The withdrawal of many Western companies from the Russian market and those niches that have been vacated may actually be occupied by India...
- Indian pharma major Dr. Reddy's plans 'business continuity' in RussiaNo Indian company has publicly withdrawn from Russia and New Delhi has declined to condemn Moscow's invasion of Ukraine, despite pressure f...
- Dr Reddy's to acquire select brands from Glenmark in Russia, UkraineDr Reddy's Laboratories on Saturday said it has inked a pact with Glenmark Pharmaceuticals to acquire its select anti-allergy brands in Rus...
- Prolonged crisis in Ukraine may affect Indian pharma companiesA prolonged crisis in Ukraine could hit Indian pharmaceutical companies by raising the end cost of the items shipped by them.
- Cadila Pharmaceuticals looking to set up $150 million manufacturing unit in AstrakhanThe company is looking for an opportunity in Astrakhan to acquire land for setting up manufacturing unit in that country.
- Bafna Pharma IPO to open on May 27Bafna Pharmaceuticals Ltd is entering the capital market with an offering of 64,00,000 equity shares of Rs 10 each for cash at premium of R...
- Venus' second research product in UkrainePharmaceutical company Venus Remedies has received regulatory approval for marketing its second research product in Ukraine.
Load More
